Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2026)
Ovid Therapeutics filings provide 5 years of Amortizatization of Intangibles readings, the most recent being $312000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 8.33% to $312000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, up 8.22% year-over-year, with the annual reading at $1.2 million for FY2025, 8.2% up from the prior year.
- Amortizatization of Intangibles hit $312000.0 in Q1 2026 for Ovid Therapeutics, up from $305000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $354185.0 in Q2 2022 and bottomed at $253000.0 in Q1 2023.
- Average Amortizatization of Intangibles over 5 years is $280818.8, with a median of $274500.0 recorded in 2024.
- The largest annual shift saw Amortizatization of Intangibles fell 27.16% in 2023 before it increased 8.33% in 2026.
- Ovid Therapeutics' Amortizatization of Intangibles stood at $254970.0 in 2022, then grew by 2.36% to $261000.0 in 2023, then increased by 8.05% to $282000.0 in 2024, then increased by 8.16% to $305000.0 in 2025, then rose by 2.3% to $312000.0 in 2026.
- Per Business Quant, the three most recent readings for OVID's Amortizatization of Intangibles are $312000.0 (Q1 2026), $305000.0 (Q4 2025), and $300000.0 (Q3 2025).